{"id":8947,"date":"2018-04-17T12:06:37","date_gmt":"2018-04-17T12:06:37","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=8947"},"modified":"2026-07-27T13:24:13","modified_gmt":"2026-07-27T07:54:13","slug":"t-cell-immunotherapies-the-goldrush-continues","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/","title":{"rendered":"T-Cell Immunotherapies: The Goldrush Continues"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Amidst the current initiatives to develop more targeted anti-cancer therapies, immunotherapy has emerged as a highly potent option to eradicate tumor cells with minimal side effects. It is based on the principle of harnessing the innate potential of the immune system to target and destroy diseased cells. It encompasses several treatment approaches, such as monoclonal antibodies, immune checkpoint inhibitors, therapeutic vaccines, cytokine therapies and cell-based therapies. In recent years, adoptive T-Cell Immunotherapies has emerged as a potent and viable therapeutic intervention.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>Social Media is Abuzz With the Growing Interest in T-Cell Immunotherapies<\/b><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Exponential increase in the number of tweets on the social medial platform, Twitter, indicates the rising interest in the field of T-cell immunotherapy.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>Opinions Solicited from Various Stakeholders Validate the Future Potential<\/b><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The widening optimism, confirmed from several industry \/ academia stakeholders, is indicative of the lucrative future potential.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>Both Industry and Non-Industry Players are Actively Contributing<\/b><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The research landscape has steadily grown as several industry \/ non-industry players across the globe have made notable contributions to this field.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>An Already Robust Pipeline Holds Significant Promise<\/b><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Currently, a variety of candidates, primarily CAR-T products, are being evaluated across various stages of development<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"429\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapies-Various-Stages-of-Development-Roots.webp\" alt=\"Around 75% of the T-cell immunotherapies are used to offer CAR-T Therapy wherein 136 are currently in discovery stage and majorly developed by industry players.\" class=\"wp-image-18139\" style=\"object-fit:contain;width:800px;height:508px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapies-Various-Stages-of-Development-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapies-Various-Stages-of-Development-Roots-300x192.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>Several New Targets and Indications are Being Explored<\/b><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Many novel, disease-specific targets have been discovered and are being explored for the treatment of a diverse range of oncological indications.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>Key Opinion Leaders Continue to Play a Pivotal Role<\/b><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A number of prominent scientists, acting as key opinion leaders, have led the clinical development efforts.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>As Blockbusters Emerge, We Anticipate Over 80% Annualized Growth<\/b><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">With a promising development pipeline and encouraging clinical outcomes, the market is anticipated to witness significant growth in the coming decade<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"383\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapies-Market-Growth-upto-2030-Roots.webp\" alt=\"The T-cell immunotherapy market is fragmented across various segments and the market is anticipated to grow at 80% annualized growth by 2030 \" class=\"wp-image-18140\" style=\"object-fit:contain;width:800px;height:450px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapies-Market-Growth-upto-2030-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapies-Market-Growth-upto-2030-Roots-300x171.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><b>Realizing the Future Potential, Several CMOs have Surfaced to Cater to Increasing Demand<\/b><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">CMOs offering manufacturing services for different types of cell-based therapies have become an indispensable asset in this emerging market<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"419\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Therapy-Manufacturing-CMO-Landscape-Roots.webp\" alt=\"Currently, around 40 T-cell therapy CMO are currently present in market. Majority of them are based in North America\" class=\"wp-image-18141\" style=\"object-fit:contain;width:800px;height:500px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Therapy-Manufacturing-CMO-Landscape-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Therapy-Manufacturing-CMO-Landscape-Roots-300x187.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Therapy-Manufacturing-CMO-Landscape-Roots-200x125.webp 200w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Our Social Media Platform<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Web:&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/\">https:\/\/www.rootsanalysis.com\/<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">LinkedIn:&nbsp;<a href=\"https:\/\/in.linkedin.com\/company\/roots-analysis\">https:\/\/in.linkedin.com\/company\/roots-analysis<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Twitter:&nbsp;<a href=\"https:\/\/twitter.com\/RootsAnalysis\">https:\/\/twitter.com\/RootsAnalysis<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Amidst the current initiatives to develop more targeted anti-cancer therapies, immunotherapy has emerged as a highly potent option to eradicate tumor cells with minimal side effects. It is based on the principle of harnessing the innate potential of the immune system to target and destroy diseased cells. It encompasses several treatment approaches, such as monoclonal [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":11993,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[99,86,58],"tags":[68,271],"class_list":["post-8947","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biologics","category-immunotherapy","category-oncology","tag-social-media","tag-t-cell-immunotherapies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Why the T-Cell Immunotherapy Goldrush Isn&#039;t Slowing Down<\/title>\n<meta name=\"description\" content=\"Amidst the current initiatives to develop more targeted anti-cancer therapies, t-cell immunotherapies has emerged as a highly potent option\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why the T-Cell Immunotherapy Goldrush Isn&#039;t Slowing Down\" \/>\n<meta property=\"og:description\" content=\"Amidst the current initiatives to develop more targeted anti-cancer therapies, t-cell immunotherapies has emerged as a highly potent option\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-17T12:06:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-27T07:54:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/04\/scs.png\" \/>\n\t<meta property=\"og:image:width\" content=\"328\" \/>\n\t<meta property=\"og:image:height\" content=\"201\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Arun Gupta\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arun Gupta\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/\"},\"author\":{\"name\":\"Arun Gupta\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\"},\"headline\":\"T-Cell Immunotherapies: The Goldrush Continues\",\"datePublished\":\"2018-04-17T12:06:37+00:00\",\"dateModified\":\"2026-07-27T07:54:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/\"},\"wordCount\":336,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/scs.png\",\"keywords\":[\"Social Media\",\"T-Cell Immunotherapies\"],\"articleSection\":[\"Biologics\",\"Immunotherapy\",\"Oncology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/\",\"name\":\"Why the T-Cell Immunotherapy Goldrush Isn't Slowing Down\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/scs.png\",\"datePublished\":\"2018-04-17T12:06:37+00:00\",\"dateModified\":\"2026-07-27T07:54:13+00:00\",\"description\":\"Amidst the current initiatives to develop more targeted anti-cancer therapies, t-cell immunotherapies has emerged as a highly potent option\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/scs.png\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/scs.png\",\"width\":328,\"height\":201,\"caption\":\"Rootsanalysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapies-the-goldrush-continues\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"T-Cell Immunotherapies: The Goldrush Continues\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\",\"name\":\"Arun Gupta\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"caption\":\"Arun Gupta\"},\"description\":\"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Why the T-Cell Immunotherapy Goldrush Isn't Slowing Down","description":"Amidst the current initiatives to develop more targeted anti-cancer therapies, t-cell immunotherapies has emerged as a highly potent option","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/","og_locale":"en_US","og_type":"article","og_title":"Why the T-Cell Immunotherapy Goldrush Isn't Slowing Down","og_description":"Amidst the current initiatives to develop more targeted anti-cancer therapies, t-cell immunotherapies has emerged as a highly potent option","og_url":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2018-04-17T12:06:37+00:00","article_modified_time":"2026-07-27T07:54:13+00:00","og_image":[{"width":328,"height":201,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/04\/scs.png","type":"image\/png"}],"author":"Arun Gupta","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Arun Gupta","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/"},"author":{"name":"Arun Gupta","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62"},"headline":"T-Cell Immunotherapies: The Goldrush Continues","datePublished":"2018-04-17T12:06:37+00:00","dateModified":"2026-07-27T07:54:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/"},"wordCount":336,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/04\/scs.png","keywords":["Social Media","T-Cell Immunotherapies"],"articleSection":["Biologics","Immunotherapy","Oncology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/","url":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/","name":"Why the T-Cell Immunotherapy Goldrush Isn't Slowing Down","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/04\/scs.png","datePublished":"2018-04-17T12:06:37+00:00","dateModified":"2026-07-27T07:54:13+00:00","description":"Amidst the current initiatives to develop more targeted anti-cancer therapies, t-cell immunotherapies has emerged as a highly potent option","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/04\/scs.png","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/04\/scs.png","width":328,"height":201,"caption":"Rootsanalysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies-the-goldrush-continues\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"T-Cell Immunotherapies: The Goldrush Continues"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62","name":"Arun Gupta","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","caption":"Arun Gupta"},"description":"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients."}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=8947"}],"version-history":[{"count":4,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8947\/revisions"}],"predecessor-version":[{"id":22563,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8947\/revisions\/22563"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/11993"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=8947"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=8947"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=8947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}